Intriguingly, CaSR antagonists were shown to reduce CaSR expression levels, brain tissue loss and neurological deficits, in animal models of traumatic brain injury and cerebral ischemia (Kim et al., 2013, 2014). This evidence concerns the gene CASR and Cerebral ischemia.